Midgard Science

Aptamer Group

York, United Kingdom aptamergroup.com

From their website, Nov 2026

Work here? Claim this listing

About

Aptamer Group develops custom Optimer® aptamer binders and related assay solutions for life sciences customers. It works with global pharmaceutical, diagnostic, biotech, and bioprocessing organizations from its York, UK site.

Services

  • Custom Optimer® development

    Custom solutions using the Optimer® affinity platform to solve targeting challenges from early discovery through clinical development.

  • Biomarker discovery service

    Discovery and validation of novel biomarkers by comparing healthy and diseased cell phenotypes, including cell-surface and intracellular protein targets.

  • Custom development workflow

    A staged workflow covering consultation, in vitro selection, clonal analysis and Optimer development, assay development, and supply.

  • Bioprocessing solutions

    Optimer-based affinity purification and quality control reagents for bioprocessing and manufacturing workflows.

  • Assay development

    Characterisation, validation, and development of application-ready assays for custom Optimer binders.

  • Custom bioanalytical reagents

    Development of Optimer reagents as antibody alternatives for detection and quantification assays in plasma, serum, or tissue.

  • Optimer binders to license

    Optimer binders available to trial or license with custom modifications for platform integration.

  • Optimer® binder licensing

    Provides Optimer® binders available to trial or license with custom modifications for platform integration.

  • Therapeutics development

    Develops Optimer® binders for therapeutic inhibitors, modulators, and targeted delivery applications.

  • Diagnostics and reagents

    Develops Optimer® binders for diagnostic and research assays.

  • Biomarker discovery

    Identifies biomarkers from healthy versus disease-state cells using Optimer-based phenotypic discovery.

Turnaround
From weeks to months
What to send
Targets can be cells, proteins and peptides, or small molecules. · Comparisons may use different tissues, liquid biopsies, or healthy vs. diseased cell models.

Capabilities

Assays and studies
ELISA · SPR · BLI · Flow cytometry · FACS · Cell-based inhibition/activation assays · Affinity chromatography · WB · Fluorescence microscopy · IHC · Luminex · Enzyme activity assays
4 moreImmunocytochemistry · Cell viability and proliferation assays · Apoptosis and internalisation assays · Biolayer interferometry
Scale and capacity
Manufacturing scale
Therapeutic areas
Therapeutics · Diagnostics · Bioprocessing · Drug delivery · Biomarker discovery · Oncology · Neurology · Metabolism · Radiopharmaceuticals · Alzheimer's disease

Instruments and platforms

  • Octet RH16
  • Biolayer interferometry
  • Mass spectrometry

Modalities and species

Modalities
Small molecule · Antibody · Peptide · Oligonucleotide
Species and models
Cells · Primary fibrotic liver cells · Primary fibrotic hepatic stellate cells · Healthy cells · Diseased cells · Cancer cells · Healthy vs diseased cell models · Cancer vs healthy · Resistant vs sensitive · Activated vs quiescent · Liquid biopsies

Industries served

  • Pharmaceutical
  • Diagnostic
  • Biotech
  • Bioprocessing
  • Consumer cosmetic

Company

Quality
ICH M10 (bioanalytical method validation guideline naming aptamers among binding reagents)

Locations

Address
29 Wellington Street Leeds LS1 4DL All enquiries concerning your shareholding should be di
Sites
York, UK
Serves
global

Contacts

Public records

Parent company
APTAMER GROUP PLC · GB GLEIF

Similar labs

Work here? Claim this listing